Soluble receptor for advanced glycation end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis and funisitis (Q47418383)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 21, 2010

Language	Label	Description	Also known as
English	Soluble receptor for advanced glycation end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis and funisitis	scientific article published on August 21, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Soluble receptor for advanced glycation end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis and funisitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

1 reference

based on heuristic

inferred from title

Marta Szymankiewicz-Bręborowicz

5

object named as

Marta Szymankiewicz

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

author name string

Wolfgang Thomas

1

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Silvia Seidenspinner

2

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Natalia Kawczyńska-Leda

3

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Johannes Wirbelauer

4

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Marta Szymankiewicz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20727688

20 June 2024

Christian P. Speer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20727688

20 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20727688

20 June 2024

publication date

21 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

full work available at URL

https://api.elsevier.com/content/article/PII:S0378378210002008?httpAccept=text/xml

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

https://api.elsevier.com/content/article/PII:S0378378210002008?httpAccept=text/plain

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Early Human Development

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

86

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

9

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

593-598

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

1

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Understanding RAGE, the receptor for advanced glycation end products

2

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

HMGB1 and RAGE in inflammation and cancer

3

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

4

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

5

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Identification, classification, and expression of RAGE gene splice variants

6

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease

7

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

8

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung

9

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Receptor for advanced glycation end-products is a marker of type I lung alveolar cells

10

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene

11

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung

12

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology

13

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.

14

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice

15

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

16

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

The role of nuclear factor kappa B in human labour

17

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation

18

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation

19

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study

20

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome

21

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis

22

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis

23

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia

24

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants

25

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only.

26

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury

27

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age

28

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants

29

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia

31

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Serum and glucocorticoid-inducible kinase in pulmonary tissue of preterm fetuses exposed to chorioamnionitis

32

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

33

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

sRAGE is elevated in septic patients and associated with patients outcome

34

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin

36

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Intravenous lipopolysaccharide-induced pulmonary maturation and structural changes in fetal sheep

37

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Endotoxin-induced Chorioamnionitis Modulates Innate Immunity of Monocytes in Preterm Sheep

38

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep.

39

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance

40

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network

42

1 reference

10.1016/J.EARLHUMDEV.2010.07.013

https://api.crossref.org/works/10.1016/J.EARLHUMDEV.2010.07.013

20 June 2024

Identifiers

10.1016/J.EARLHUMDEV.2010.07.013

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/20727688

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47418383&oldid=2216166361"